A neuroscience biotech startup developing small molecule inhibitors targeting mitochondrial dysfunction in neurodegenerative diseases such as ALS and Parkinson's.
Investment Rounds
Capital activity and funding progression
| Amount | Date | Round |
|---|---|---|
| €50 M | Sep, 2025 | series-b |
Industries
Frequently Asked Questions
What industries does NRG Therapeutics operate in?
NRG Therapeutics operates in the following industries: biotechnology, neuroscience, pharmaceuticals.
How much total funding has NRG Therapeutics raised?
NRG Therapeutics has raised a total of $50,000,000.
Who are the investors in NRG Therapeutics?
The investors in NRG Therapeutics are: SV Health Investors' Dementia Discovery Fund, British Business Bank, M Ventures, Novartis Venture Fund, Criteria Bio Ventures, Omega Funds, Brandon Capital.